SCHEMBL5034419

SCHEMBL5034419

O=C(Nc1nc(NC2CCCC2)c2ncn(C3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1)c1cn[nH]c1

nearest known ligand 0.70

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 9/20 0.70
ADORA1 P30542 8/20 0.70
ADORA2A P29274 3/20 0.70
ADORA2B P29275 1/20 0.64
MEN1 O00255 1/20 0.64
CYP1A2 P05177 1/20 0.64
MAPK1 P28482 1/20 0.64
KMT2A Q03164 1/20 0.64
RXFP1 Q9HBX9 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5034108 1.00 ADORA3 (0.70) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL5034551 0.99 ADORA3 (0.69) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL5031749 0.88 ADORA3 (0.69) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL3423089 0.84 ADORA2A (0.68) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL5032129 0.83 ADORA3 (0.66) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL999074 0.82 ADORA3 (0.72) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL999075 0.82 ADORA3 (0.72) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL3952630 0.82 ADORA2A (0.76) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL5033794 0.82 ADORA2A (0.76) ADORA3ADORA1ADORA2AADORA2BMEN1
SCHEMBL4803658 0.81 ADORA2A (0.75) ADORA3ADORA1ADORA2AADORA2BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881991-A1 A1 ADENOSINE RECEPTOR AGONISTS CV THERAPEUTICS, INC. (US) 2008-01-30 EP claimed
WO-2006125211-A1 A1 ADENOSINE RECEPTOR AGONISTS CV THERAPEUTICS, INC. (US) 2006-11-23 WO claimed
EP-1881991-A1 A1 ADENOSINE RECEPTOR AGONISTS CV THERAPEUTICS, INC. (US) 2008-01-30 EP disclosed
WO-2006125211-A1 A1 ADENOSINE RECEPTOR AGONISTS CV THERAPEUTICS, INC. (US) 2006-11-23 WO disclosed